查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1840806

恒溫核酸增幅技術市場：依產品類型、工作流程、平台、技術、最終用戶和應用分類－2025-2032年全球預測

Isothermal Nucleic Acid Amplification Technology Market by Product Type, Workflow, Platform, Technology, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，恒溫核酸增幅技術市場規模將達到 122.7 億美元，複合年成長率為 14.17%。

關鍵市場統計數據
基準年 2024 42.5億美元
預計年份：2025年 48.5億美元
預測年份 2032 122.7億美元
複合年成長率 (%) 14.17%

為決策者恒溫核酸增幅技術的策略方向，以明確其診斷效用、研究重點和分散式檢測途徑。

恒溫核酸增幅已從一項專門的實驗室技術發展成為一個實用平台，在診斷、監測和分散式檢查領域具有廣泛的應用前景。此技術系列為熱感循環法提供了替代方案，能夠簡化設備、縮短結果取得時間，並適用於照護現場和資源受限的環境。隨著相關人員尋求兼顧敏感度、特異性和易用性的診斷方法，等溫擴增技術在臨床診斷、環境監測和生物安全戰略藍圖中的重要性日益凸顯。

本執行摘要概述了關鍵技術特性、應用促進因素和策略考量，旨在為產品開發、商業化和採購決策提供資訊。摘要重點比較了核心方法之間的實際差異，闡明了檢測化學與儀器設計之間的相互關係，並著重指出了監管和報銷框架與商業化時間表的交匯點。其目的是為技術團隊、業務領導者和相關人員提供簡潔明了、切實可行的指導，幫助他們在不依賴專有資料集和數值預測的情況下，明確工作重點。

本書著重探討設計選擇的實際操作影響，以及影響產品採納的系統性因素，例如供應鏈、監管路徑和臨床需求。為此，引言部分奠定了基礎，為後續章節的深入分析提供了支撐，並幫助讀者確定資源投入方向，從而獲得最大的策略回報。

全面審視正在積極重塑熱感核酸擴增技術全球部署的技術、監管、臨床應用和供應鏈轉變。

恒溫核酸增幅技術格局正受到多種因素的共同影響而重塑，這些因素的影響遠不止於單一實驗室的創新。酵素、探針化學和整合光學技術的進步正在縮小照護現場設備與集中式檢測系統之間的功能差距，使開發人員能夠在受限環境下設計出滿足嚴格臨床要求的檢測方法。同時，法律規範也在不斷發展以適應分散式診斷，越來越多的監管機構明確了性能預期和臨床驗證方法。這些監管變革消除了精心設計的解決方案進入市場的壁壘，並激勵製造商優先考慮以使用者為中心的設計。

在營運層面，供應鏈現代化和策略夥伴關係正在改變組件和耗材的採購和整合方式。製造商正在採用模組化設計理念，以實現跨應用情境和地區的靈活性，而儀器製造商和試劑供應商之間的夥伴關係正在加快新檢測方法的上市速度。在臨床層面，檢測週轉時間、易用性和與診療路徑的整合正在推動檢測方法的應用。隨著臨床醫生認知到快速、可靠的分子檢測結果的持續價值，採購偏好正在轉向能夠在診療現場或附近提供可操作資訊的平台。

最後，公共衛生和私人投資的資金籌措優先事項正轉向那些兼具擴充性和韌性的解決方案。技術成熟度、監管清晰度、供應鏈適應性和臨床需求的融合，創造了一個動態環境，轉化應用的成功取決於產品特性與面向最終用戶的清晰價值命題以及可預測的營運模式的契合度。

本分析重點在於 2025 年美國關稅對等溫測試的零件採購、成本結構、監管一致性和跨境合作的累積影響。

2025年美國關稅政策為等熱感核酸擴增生態系中的供應商和終端用戶帶來了一系列新的限制和決策點。關稅不僅影響最終設備價格，還會影響關鍵子組件、專用酵素和進口耗材的邊際成本。對於依賴複雜跨國供應鏈的製造商而言，關稅政策凸顯了供應商多元化、近岸外包以及合約彈性的重要性，以確保在維持毛利率的同時，也能保證可預測的交貨時間。

臨床實驗室和公共衛生機構的採購團隊正在積極應對，重新評估供應商合格，並擴大核准供應商名單，納入能夠提供更快前置作業時間和免稅價格的區域製造商和分銷商。這促使他們重新評估對單一供應商的依賴，並強調多元化採購策略。同時，研發團隊也正在重新審視組件選擇和材料採購，以減少對影響檢測化學決策和儀器組件配置的關稅敏感投入品的依賴。

監管和合規部門也受到影響，因為替代供應商通常會引入新的技術文件、品質系統調整和驗證要求。更重要的是，關稅帶來的成本壓力正在改變某些產品形式的經濟效益：設計師和銷售團隊正在權衡是否能夠接受性能上的妥協，以換取更大的供應彈性或更低的到岸成本。關稅的淨影響遠不止於直接的價格變化，它也重塑了整個價值鏈的策略採購、產品藍圖和夥伴關係關係結構。

深入解讀產品類型、工作流程、平台、技術、最終用戶和應用等方面的詳細細分數據，為商業化和研發重點提供資訊。

將市場區隔轉化為營運洞察，需要將產品系列、工作流程、平台、技術、最終用戶和應用與具體的價值提案進行清晰的繪製。依產品類型分類，我們分為儀器、試劑和套件以及軟體和服務。儀器又分為桌上型和可攜式；試劑和試劑套件細分為品管、酵素、預混液和引子/探針；軟體和服務則分為服務和軟體產品。就工作流程而言，包括擴增、檢測/分析和預分析階段，其中檢測/分析又進一步細分為終點檢測和即時檢測方法。平台細分強調專用儀器和相容於多種儀器的試劑組之間的差異。

此技術細分包括解旋酶依賴性擴增、恒溫環型核酸擴增、切口酵素增殖、重組酶聚合酵素擴增和鏈置換擴增。環介恒溫環型核酸擴增的特徵在於其比色法、螢光和濁度法檢測，而重組酶聚合酵素通常採用螢光、側向流動法和即時檢測模式。最終用戶包括學術和研究機構、醫院和診斷實驗室、製藥和生物技術公司以及即時檢測（POC​​）中心，每個用戶都有不同的採購週期和驗證要求。應用領域涵蓋環境檢測、食品和飲料檢測、基因檢測和篩檢、感染疾病診斷以及獸醫診斷，每種應用對檢測靈敏度、通量和監管要求各不相同。

試劑化學性質和酵素製劑往往決定著檢測性能，儀器決定操作環境和使用者體驗，而軟體和服務則保障著資料管理和法規遵循。各環節之間的相互作用表明，在模組化、互通性和供應鏈彈性方面的投資將對商業化和臨床應用產生最大的影響。

區域情報比較分析美洲、歐洲、中東和非洲以及亞太地區的市場動態、基礎設施準備、管理體制和夥伴關係生態系統。

在恒溫核酸增幅領域，區域差異導致開發商、製造商和買家的優先事項各不相同。美洲地區擁有眾多創新中心，並透過商業和公共衛生管道採購大量診斷試劑，因此需要可擴展的平台，以便與實驗室資訊系統和臨床工作流程整合。該地區的監管路徑強調分析的嚴謹性和臨床驗證，而買家則優先考慮互通性、供應的連續性和服務網路。

歐洲、中東和非洲：歐洲、中東和非洲的監管和基礎設施環境各不相同，需要靈活的解決方案。雖然歐洲部分地區已建立的監管協調機制支援醫院實驗室採用高複雜度平台，但中東和非洲市場通常更注重便攜性、穩健性和低溫運輸的依賴性。經銷夥伴和本地監管專業知識對於在這個多元化地區開展業務至關重要，並能確保解決方案符合區域性能和文件標準。

亞太地區兼具快速成長的市場和大規模的生產能力。公共衛生措施和私部門投資正在推動亞太多個國家快速採用分散式診斷技術。該地區還擁有強大的試劑和組件生產能力，能夠實現經濟高效的供應，但可能需要嚴格的品質監控。在整個亞太地區取得成功取決於產品設計與當地臨床路徑的契合度、服務模式的最佳化以及能夠滿足城市和分散式需求的流通結構的建立。

綜合競爭格局揭示了熱感解決方案主要參與者的策略定位、合作機會、創新差異化因素和市場策略。

等溫核酸擴增領域的競爭地位取決於獨特的化學原理、儀器架構、監管資格和管道覆蓋範圍的綜合考量。成熟的儀器供應商憑藉強大的工程技術、檢驗的平台生態系統和完善的服務網路脫穎而出，從而降低臨床應用者的操作風險。試劑和套件供應商若能達到批次間性能的一致性，並在檢測穩定性方面展現出顯著優勢，則將在診斷實驗室和分散式檢查機構中獲得廣泛認可。能夠促進資料整合、品管和監管文件編制的軟體和服務供應商，則透過消除應用障礙，為企業增添策略價值。

儀器製造商與試劑開發商之間的夥伴關係能夠加快產品上市速度，並改善終端用戶體驗。小型專業公司通常負責開發新型化學方法和檢測模式，而大型企業則在生產、分銷和監管合規方面提供規模優勢。強調模組化、開放介面和檢驗的互通性的差異化策略可以減少採購摩擦，並促進客戶採用。同時，投資可靠的臨床檢驗研究和透明的性能數據的公司能夠贏得實驗室主任和醫療採購人員的信任。

綜合這些因素，那些能夠在技術創新和營運成熟度之間取得平衡的公司更受青睞。能夠清楚闡述與特定應用情境成果（例如更快獲得結果、更低的營運總成本以及在分散式環境中提高診斷準確性）相關的價值主張的提案，將更有利於建立必要的夥伴關係，從而拓展臨床應用並實現商業性成功。

為產業領導者提供切實可行的營運、商業和創新建議，以加速等溫診斷技術的應用、最佳化供應鏈並獲得永續優勢。

產業領導者可以透過採取一系列有針對性的措施來加速技術普及化並確保永續優勢，這些措施包括使產品設計、供應鏈策略和商業模式與最終用戶需求保持一致。首先，應優先考慮儀器和檢測設計的模組化，使單一平台能夠支援多種應用場景，並降低客戶現場的庫存複雜性。這不僅可以降低採用者的整體擁有成本，還能提高耗材收入。

第二，在可行的情況下，透過多通路採購和區域化生產來增強供應鏈韌性，並投資於供應商資質認證流程，以在降低關稅和物流中斷影響的同時，維持檢測性能。第三，透過儘早與監管機構溝通，明確分散式和即時檢測應用所需的證據要求，積極使預期應用場景與監管策略保持一致。第四，加強儀器製造商、試劑開發商和資料管理提供者之間的夥伴關係，提供整合解決方案，以減輕臨床和機構使用者的驗證負擔。

臨床實驗室重視嚴格的驗證和服務基礎設施，照護現場中心優先考慮易用性和快速週轉，而研究機構則重視靈活性和檢測客製化。實施這些建議將有助於明確差異化優勢，並清楚闡明實現可擴展、永續應用的路徑。

對調查方法進行透明的描述，包括資料收集、相關人員參與、檢驗通訊協定以及用於得出見解和結論的分析框架。

本分析所依據的研究採用了混合方法，旨在確保研究的透明度、可重複性和與相關人員的相關性。主要研究內容包括對技術負責人、採購經理和臨床終端使用者的結構化訪談，以及供應商簡報，以明確產品功能和檢驗方法。此外，還對官方監管指南、同行評審文獻和產品技術文件進行了系統性審查，以驗證有關性能、效用和部署環境的各項聲明的有效性。

資料檢驗包括將供應商說明與獨立的臨床評估（如有）進行交叉比對，並透過與分銷合作夥伴和零件供應商訪談來評估供應鏈聲明。分析框架著重於價值鏈映射、技術成熟度評估和用例匹配。在整個過程中，我們始終專注於記錄假設並識別證據不足的領域。

這種方法兼顧深度和廣度，強調相關人員的觀點，使技術主張立足於實際營運，同時利用已記錄的性能數據來支持定性見解。最終形成一套結構化、可審計的結論，旨在為產品策略、採購決策和夥伴關係關係審核提供資訊，而無需依賴專有的數值估算。

本文對等溫核酸檢測的技術發展軌跡、監管影響和商業性途徑進行了簡明扼要的總結，旨在為相關人員勾勒出一條切實可行的路徑。

本分析整合了技術、監管和商業性層面，對恒溫核酸增幅的機會和限制因素進行了全面而深入的觀點。酵素和檢測方法的創新顯著拓展了其潛在應用場景，催生了從高通量桌上型系統到攜帶式即時檢測設備等多種解決方案。不斷完善的監管法規和臨床對分散式分子診斷日益成長的認知正在降低該技術的應用門檻，而供應鏈因素和關稅則影響著實際可行的實施方案。

對於相關人員，成功的關鍵在於平衡技術卓越性和營運實用性。儀器和檢測方法開發商必須將經過檢驗的性能與穩健的籌資策略和清晰的支援模式相結合。臨床應用者應優先考慮能夠清楚整合到工作流程和資料系統中的解決方案，而採購者則必須權衡儀器初始成本與後續耗材和服務成本之間的關係。

最後，未來的發展方向是強調互通性、在預期使用情境中檢驗的效能，以及能夠降低早期採用者風險的商業模式。關注這些要素將有助於把技術潛力轉化為在診斷、研究、環境和獸醫應用領域中可衡量的影響。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將基於智慧型手機的螢光檢測技術整合到環介導等溫擴增檢測中，用於照護現場診斷應用
  • 利用CRISPR-Cas12偶聯等溫擴增平台進行現場病原體快速檢測
  • 開發一種凍乾試劑配方，使重組酶聚合酵素擴增試劑套件能夠在常溫儲存。
  • 多重數位等溫擴增技術在資源匱乏的實驗室中用於同時定量病毒RNA標靶的出現
  • 用於自動化恒溫核酸增幅和樣品製備工作流程的微流體實驗室晶片裝置的實現

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章恒溫核酸增幅技術市場（依產品類型分類）

  • 裝置
    • 工作台
    • 可攜式的
  • 試劑和套件
    • 控制材料
    • 酵素
    • 母帶混音
    • 引子和探針
  • 軟體和服務
    • 服務
    • 軟體

第9章恒溫核酸增幅技術市場（依工作流程分類）

  • 放大
  • 檢測與分析
    • 端點檢測
    • 即時偵測
  • 分析之前

第10章恒溫核酸增幅技術市場（依平台分類）

  • 裝置
  • 試劑組

第11章恒溫核酸增幅技術市場（依技術分類）

  • 解旋酶依賴性擴增
  • 環介導等溫擴增
    • 比色檢測
    • 螢光偵測
    • 濁度檢測
  • 切口酵素增殖反應
  • 重組聚合酵素擴增
    • 螢光偵測
    • 側向流動檢測
    • 即時偵測
  • 鏈置換擴增

第12章恒溫核酸增幅技術市場（依最終用戶分類）

  • 學術研究機構
  • 醫院和診斷實驗室
  • 製藥和生物技術公司
  • 照護現場中心

第13章恒溫核酸增幅技術市場：依應用領域分類

  • 環境測試
  • 食品和飲料檢驗
  • 基因檢測和篩檢
  • 感染疾病診斷
  • 獸醫診斷

第14章恒溫核酸增幅技術市場（依地區分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章恒溫核酸增幅技術市場（依組別分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國等恒溫核酸增幅技術市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Abbott Laboratories
    • Roche Holding AG
    • Thermo Fisher Scientific Inc.
    • QIAGEN NV
    • Bio-Rad Laboratories, Inc.
    • Merck KGaA
    • Meridian Bioscience, Inc.
    • Eiken Chemical Co., Ltd.
    • OptiGene Ltd.
    • Bio-Techne Corporation
Product Code: MRR-B9334AD6C2E2

The Isothermal Nucleic Acid Amplification Technology Market is projected to grow by USD 12.27 billion at a CAGR of 14.17% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.25 billion
Estimated Year [2025] USD 4.85 billion
Forecast Year [2032] USD 12.27 billion
CAGR (%) 14.17%

A strategic orientation to isothermal nucleic acid amplification technologies that frames diagnostic utility, research priorities, and decentralized testing pathways for decision-makers

Isothermal nucleic acid amplification has matured from a specialized laboratory technique into a practical platform with broad implications for diagnostics, research, and decentralized testing. The technology family provides alternatives to thermal cycling, enabling simpler instrumentation, faster time-to-result, and configurations that are well suited to point-of-care and resource-constrained environments. As stakeholders seek diagnostics that balance sensitivity, specificity, and operational ease, isothermal approaches are increasingly central to strategic roadmaps in clinical diagnostics, environmental monitoring, and biosecurity.

This executive summary synthesizes key technological characteristics, adoption drivers, and strategic considerations that should inform decision-making across product development, commercialization, and procurement. It emphasizes practical comparators among core methods, clarifies the interplay between assay chemistry and instrument design, and highlights where regulatory and reimbursement frameworks intersect with commercialization timelines. The objective is to present a concise, actionable orientation that helps technical teams, business leaders, and policy stakeholders align on priorities without delving into proprietary datasets or numeric projections.

Throughout the narrative, emphasis is placed on the operational implications of design choices and on the systemic forces-supply chains, regulatory pathways, and clinical needs-that influence uptake. By doing so, the introduction establishes a baseline understanding that supports deeper analysis in the following sections and primes readers to identify where investment of resources will produce the greatest strategic return.

A comprehensive view of the transformative technological, regulatory, clinical adoption, and supply chain shifts that are actively reshaping isothermal nucleic acid amplification deployment worldwide

The landscape for isothermal nucleic acid amplification is being reshaped by several converging forces that go beyond individual laboratory innovations. Technological progress in enzymes, probe chemistry, and integrated optics has reduced the functional gap between point-of-care devices and centralized laboratory systems, allowing developers to design assays that meet stringent clinical requirements while operating in constrained settings. Concurrently, regulatory frameworks are evolving to accommodate decentralized diagnostics, with agencies increasingly providing clarity on performance expectations and clinical validation approaches. These regulatory shifts remove barriers to market entry for well-designed solutions and incentivize manufacturers to prioritize user-centric design.

Operationally, supply chain modernization and strategic partnerships have changed how components and consumables are sourced and integrated. Manufacturers are adopting modular design philosophies to enable flexibility across use cases and geographies, and partnerships between instrument makers and reagent providers are accelerating time-to-deployment for new assays. Clinically, adoption patterns are driven by test turnaround time, ease of use, and integration into care pathways; as clinicians see consistent value in rapid, reliable molecular results, procurement preferences shift toward platforms that deliver actionable information at or near the point of care.

Finally, funding priorities in public health and private investment are tilting toward solutions that demonstrate both scalability and resilience. This convergence of technical maturity, regulatory clarity, supply chain adaptation, and clinical demand is producing a dynamic environment in which translational success depends on aligning product features with clear end-user value propositions and predictable operational models.

A focused analysis of the cumulative effects of United States tariff actions in 2025 on component sourcing, cost structures, regulatory alignment, and cross-border collaboration in isothermal testing

United States tariff actions in 2025 have created a new set of constraints and decision points for suppliers and end users across the isothermal nucleic acid amplification ecosystem. Tariffs affect not only final device pricing but also the marginal cost of critical subcomponents, specialty enzymes, and imported consumables. For manufacturers that rely on complex, multinational supply chains, tariffs increase the importance of supplier diversification, nearshoring options, and contractual flexibility to preserve gross margins while maintaining predictable delivery schedules.

Procurement teams in clinical laboratories and public health agencies have responded by revisiting supplier qualifications and expanding approved vendor lists to include regional manufacturers and distributors who can offer shorter lead times or tariff-insulated pricing. This has led to a re-evaluation of single-supplier dependencies and an emphasis on multi-sourcing strategies. At the same time, research and development groups are reconsidering component selection and material sourcing to reduce exposure to tariff-sensitive inputs, which can influence assay chemistry decisions and instrument bill-of-materials composition.

Regulatory and compliance functions are also implicated because alternative suppliers often introduce new technical documentation, quality system alignments, and validation requirements. Importantly, tariff-induced cost pressures have altered the economics of certain product formats: designers and commercial teams are assessing whether incremental performance trade-offs are acceptable when they deliver greater supply resilience or lower landed cost. The net effect of tariffs extends beyond immediate price changes; it reshapes strategic sourcing, product roadmaps, and partnership structures across the value chain.

Insight-driven interpretation of detailed segmentation across product types, workflows, platforms, technologies, end users, and applications to inform commercialization and R&D priorities

Translating segmentation into operational insight requires a clear mapping of product families, workflows, platforms, technologies, end users, and applications to specific value propositions. Based on product type, the landscape spans Instruments, Reagents & Kits, and Software & Services; Instruments bifurcate into Benchtop and Portable platforms, Reagents & Kits subdivide into Control Materials, Enzymes, Master Mixes, and Primers & Probes, and Software & Services separate into Services and Software offerings. Considering workflow, the continuum includes Amplification, Detection & Analysis, and Preanalytical stages, with Detection & Analysis further defined by End-Point Detection and Real-Time Detection approaches. Platform segmentation highlights a distinction between dedicated Instruments and Reagent Kits that are designed for compatibility with broader instrumentation.

Technology segmentation differentiates Helicase Dependent Amplification, Loop Mediated Isothermal Amplification, Nicking Enzyme Amplification Reaction, Recombinase Polymerase Amplification, and Strand Displacement Amplification, with Loop Mediated Isothermal Amplification further characterized by Colorimetric Detection, Fluorescence Detection, and Turbidimetric Detection modalities, while Recombinase Polymerase Amplification often presents Fluorescence Detection, Lateral Flow Detection, and Real Time Detection modes. End users encompass Academic & Research Institutes, Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Point Of Care Centers, each exhibiting distinct procurement cycles and validation expectations. Applications are distributed across Environmental Testing, Food & Beverage Testing, Genetic Testing & Screening, Infectious Disease Diagnostics, and Veterinary Diagnostics, which drive differing assay sensitivity, throughput, and regulatory requirements.

When these dimensions are layered, clear patterns emerge: reagent chemistry and enzyme formulation tend to drive assay performance, instruments define operational contexts and user experience, and software and services enable data management and regulatory compliance. The interplay among segments indicates where investments in modularity, interoperability, and supply chain resilience will deliver the greatest leverage for commercialization and clinical adoption.

Region-specific intelligence that contrasts market dynamics, infrastructure readiness, regulatory regimes, and partnership ecosystems across Americas, Europe, Middle East & Africa, and Asia-Pacific

Regional variation creates differential priorities for developers, manufacturers, and purchasers in the isothermal nucleic acid amplification space. The Americas exhibit concentrated innovation centers and significant diagnostic procurement through both commercial and public health channels, creating opportunities for scalable platforms that integrate with laboratory information systems and clinical workflows. Regulatory pathways in this region emphasize rigorous analytical and clinical validation, and buyers prioritize interoperability, supply continuity, and service networks.

Europe, Middle East & Africa presents a heterogeneous regulatory and infrastructure environment that rewards adaptable solutions. In parts of Europe, established regulatory harmonization supports adoption of high-complexity platforms in hospital laboratories, while markets in the Middle East and Africa often value portability, robustness, and minimal cold-chain dependence. Distribution partnerships and local regulatory expertise are critical to navigating this diverse region and to ensuring that solutions meet localized standards for performance and documentation.

Asia-Pacific combines fast adopter markets with large-scale manufacturing capacity. In several countries within Asia-Pacific, there is rapid uptake of decentralized diagnostics driven by public health initiatives and private sector investment. The region also hosts significant production capabilities for reagents and components, which can be leveraged for cost-effective supply but may require careful quality oversight. Across all regions, success depends on aligning product design with regional clinical pathways, optimizing service models, and structuring distribution to meet both urban and decentralized demand.

A competitive landscape synthesis identifying strategic positioning, collaboration opportunities, innovation differentiators, and go-to-market approaches among key players in isothermal solutions

Competitive positioning in isothermal nucleic acid amplification is determined by a combination of proprietary chemistry, instrument architecture, regulatory pedigree, and channel reach. Established instrument suppliers differentiate through robust engineering, validated platform ecosystems, and comprehensive service networks that reduce operational risk for clinical adopters. Reagent and kit providers that achieve consistent lot-to-lot performance and demonstrate clear assay stability advantages can secure strong preferences among diagnostic laboratories and decentralized testing sites. Software and service providers that facilitate data integration, quality management, and regulatory documentation add strategic value by smoothing adoption barriers.

Collaboration potential is significant: partnerships between instrument manufacturers and reagent developers accelerate go-to-market timelines and improve end-user experience. In many instances, small specialized firms advance novel chemistries or detection modalities while larger organizations provide scale in manufacturing, distribution, and regulatory navigation. Differentiation strategies that emphasize modularity, open interfaces, and validated interoperability can reduce friction in procurement and support cross-customer adoption. In parallel, firms that invest in robust clinical validation studies and transparent performance data build trust with laboratory directors and institutional purchasers.

Taken together, these dynamics favor companies that balance technological innovation with operational maturity. Firms that can articulate clear value propositions tied to use-case specific outcomes-such as reduced time-to-result, lower total cost-of-operation, or improved diagnostic accuracy in decentralized settings-will be well positioned to form the partnerships necessary to expand clinical reach and commercial traction.

Actionable operational, commercial, and innovation recommendations for industry leaders to accelerate adoption, optimize supply chains, and capture sustainable advantage in isothermal diagnostics

Industry leaders can accelerate adoption and secure sustainable advantage by executing a set of targeted actions that align product design, supply chain strategy, and commercial models with end-user needs. First, prioritize modularity in instrument and assay design so that a single platform can support multiple use cases and reduce inventory complexity across client sites. This reduces total cost of ownership for adopters and facilitates incremental revenue from consumables.

Second, build supply resilience through multi-sourcing and regional manufacturing where feasible, and invest in supplier qualification processes that preserve assay performance while mitigating tariff or logistics disruption. Third, proactively align regulatory strategies with intended use cases by engaging with regulators early to clarify evidence requirements for decentralized and point-of-care applications. Fourth, strengthen partnerships between instrument manufacturers, reagent developers, and data management providers to deliver integrated solutions that reduce the burden of validation for clinical and institutional adopters.

Finally, tailor commercial approaches to distinct end-user segments: clinical laboratories will value rigorous validation and service infrastructures, point-of-care centers will prioritize ease of use and rapid turnaround, and research institutions will emphasize flexibility and assay customization. Implementing these recommendations will create defensible differentiation and a clearer path to scalable, sustainable adoption.

A transparent description of research methodology including data collection, stakeholder engagement, validation protocols, and analytical frameworks used to derive insights and conclusions

The research that underpins this analysis employed a mixed-methods approach designed to ensure transparency, reproducibility, and relevance to stakeholders. Primary inputs included structured interviews with technical leaders, procurement managers, and clinical end users, combined with targeted vendor briefings that clarified product capabilities and validation approaches. These qualitative engagements were complemented by systematic reviews of public regulatory guidance, peer-reviewed literature, and product technical documentation to triangulate claims about performance, usability, and deployment contexts.

Data validation included cross-referencing vendor statements with independent clinical evaluations where available, and assessing supply chain assertions through interviews with distribution partners and component suppliers. Analytical frameworks focused on value chain mapping, technology readiness assessment, and use-case alignment. Throughout the process, care was taken to document assumptions and to identify areas where evidence was limited, thereby highlighting where further primary studies or real-world evaluations would be most valuable.

This methodology balances depth and breadth: it privileges stakeholder perspectives to ground technical claims in operational reality while using documented performance data to corroborate qualitative insights. The result is a structured, auditable set of conclusions intended to inform product strategy, procurement decisions, and partnership planning without relying on proprietary numerical estimates.

A concise synthesis that brings together technological trajectories, regulatory influences, and commercial levers to outline practical pathways for stakeholders in isothermal nucleic acid testing

This analysis synthesizes technological, regulatory, and commercial dimensions to provide a coherent perspective on opportunities and constraints in isothermal nucleic acid amplification. Technological innovations in enzymes and detection modalities have meaningfully expanded use-case possibilities, enabling a range of solutions from high-throughput benchtop systems to portable point-of-care devices. Regulatory evolution and growing clinical familiarity with decentralized molecular diagnostics are lowering adoption barriers, while supply chain considerations and tariff exposures shape practical implementation choices.

For stakeholders, the implication is that success depends on aligning technical excellence with operational pragmatism. Instrument and assay developers must pair validated performance with resilient sourcing strategies and clear support models. Clinical adopters should prioritize solutions that demonstrably integrate into workflow and data systems, while purchasers must weigh trade-offs between initial device cost and downstream consumable and service dynamics.

In closing, the path forward emphasizes interoperability, validated performance in intended use contexts, and commercial models that reduce risk for early adopters. By focusing on these levers, organizations can translate technological promise into measurable impact across diagnostics, research, environmental, and veterinary applications.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of smartphone-based fluorescence detection in loop-mediated isothermal amplification assays for point-of-care diagnostics
  • 5.2. Adoption of CRISPR-Cas12 coupled isothermal amplification platforms for rapid pathogen detection in field settings
  • 5.3. Development of lyophilized reagent formulations enabling ambient temperature storage of recombinase polymerase amplification kits
  • 5.4. Emergence of multiplexed digital isothermal amplification for simultaneous quantification of viral RNA targets in low-resource laboratories
  • 5.5. Implementation of microfluidic lab-on-a-chip devices for automated isothermal nucleic acid amplification and sample preparation workflows

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Isothermal Nucleic Acid Amplification Technology Market, by Product Type

  • 8.1. Instruments
    • 8.1.1. Benchtop
    • 8.1.2. Portable
  • 8.2. Reagents & Kits
    • 8.2.1. Control Materials
    • 8.2.2. Enzymes
    • 8.2.3. Master Mixes
    • 8.2.4. Primers & Probes
  • 8.3. Software & Services
    • 8.3.1. Services
    • 8.3.2. Software

9. Isothermal Nucleic Acid Amplification Technology Market, by Workflow

  • 9.1. Amplification
  • 9.2. Detection & Analysis
    • 9.2.1. End-Point Detection
    • 9.2.2. Real-Time Detection
  • 9.3. Preanalytical

10. Isothermal Nucleic Acid Amplification Technology Market, by Platform

  • 10.1. Instruments
  • 10.2. Reagent Kits

11. Isothermal Nucleic Acid Amplification Technology Market, by Technology

  • 11.1. Helicase Dependent Amplification
  • 11.2. Loop Mediated Isothermal Amplification
    • 11.2.1. Colorimetric Detection
    • 11.2.2. Fluorescence Detection
    • 11.2.3. Turbidimetric Detection
  • 11.3. Nicking Enzyme Amplification Reaction
  • 11.4. Recombinase Polymerase Amplification
    • 11.4.1. Fluorescence Detection
    • 11.4.2. Lateral Flow Detection
    • 11.4.3. Real Time Detection
  • 11.5. Strand Displacement Amplification

12. Isothermal Nucleic Acid Amplification Technology Market, by End User

  • 12.1. Academic & Research Institutes
  • 12.2. Hospitals & Diagnostic Laboratories
  • 12.3. Pharmaceutical & Biotechnology Companies
  • 12.4. Point Of Care Centers

13. Isothermal Nucleic Acid Amplification Technology Market, by Application

  • 13.1. Environmental Testing
  • 13.2. Food & Beverage Testing
  • 13.3. Genetic Testing & Screening
  • 13.4. Infectious Disease Diagnostics
  • 13.5. Veterinary Diagnostics

14. Isothermal Nucleic Acid Amplification Technology Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Isothermal Nucleic Acid Amplification Technology Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Isothermal Nucleic Acid Amplification Technology Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Abbott Laboratories
    • 17.3.2. Roche Holding AG
    • 17.3.3. Thermo Fisher Scientific Inc.
    • 17.3.4. QIAGEN N.V.
    • 17.3.5. Bio-Rad Laboratories, Inc.
    • 17.3.6. Merck KGaA
    • 17.3.7. Meridian Bioscience, Inc.
    • 17.3.8. Eiken Chemical Co., Ltd.
    • 17.3.9. OptiGene Ltd.
    • 17.3.10. Bio-Techne Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PLATFORM, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PLATFORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY BENCHTOP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY BENCHTOP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY BENCHTOP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY BENCHTOP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY BENCHTOP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY BENCHTOP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PORTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PORTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PORTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PORTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY CONTROL MATERIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY CONTROL MATERIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY CONTROL MATERIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY CONTROL MATERIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY CONTROL MATERIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY CONTROL MATERIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY ENZYMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY ENZYMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY ENZYMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY MASTER MIXES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY MASTER MIXES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY MASTER MIXES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY MASTER MIXES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY MASTER MIXES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY MASTER MIXES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRIMERS & PROBES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRIMERS & PROBES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRIMERS & PROBES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRIMERS & PROBES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRIMERS & PROBES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PRIMERS & PROBES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY WORKFLOW, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY AMPLIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY AMPLIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY AMPLIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY AMPLIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY AMPLIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY DETECTION & ANALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-POINT DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-POINT DETECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-POINT DETECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-POINT DETECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-POINT DETECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END-POINT DETECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAL-TIME DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAL-TIME DETECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAL-TIME DETECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAL-TIME DETECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAL-TIME DETECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAL-TIME DETECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PREANALYTICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PREANALYTICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PREANALYTICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PREANALYTICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PREANALYTICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PREANALYTICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PLATFORM, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PLATFORM, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENT KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENT KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENT KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENT KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENT KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAGENT KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY HELICASE DEPENDENT AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY HELICASE DEPENDENT AMPLIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY HELICASE DEPENDENT AMPLIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY HELICASE DEPENDENT AMPLIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY HELICASE DEPENDENT AMPLIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY HELICASE DEPENDENT AMPLIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COLORIMETRIC DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COLORIMETRIC DETECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COLORIMETRIC DETECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COLORIMETRIC DETECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COLORIMETRIC DETECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COLORIMETRIC DETECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY FLUORESCENCE DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY FLUORESCENCE DETECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY FLUORESCENCE DETECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY FLUORESCENCE DETECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY FLUORESCENCE DETECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY FLUORESCENCE DETECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TURBIDIMETRIC DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TURBIDIMETRIC DETECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TURBIDIMETRIC DETECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TURBIDIMETRIC DETECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TURBIDIMETRIC DETECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY TURBIDIMETRIC DETECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY NICKING ENZYME AMPLIFICATION REACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY NICKING ENZYME AMPLIFICATION REACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY NICKING ENZYME AMPLIFICATION REACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY NICKING ENZYME AMPLIFICATION REACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY NICKING ENZYME AMPLIFICATION REACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY NICKING ENZYME AMPLIFICATION REACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY FLUORESCENCE DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY FLUORESCENCE DETECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY FLUORESCENCE DETECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY FLUORESCENCE DETECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY FLUORESCENCE DETECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY FLUORESCENCE DETECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LATERAL FLOW DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LATERAL FLOW DETECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LATERAL FLOW DETECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LATERAL FLOW DETECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LATERAL FLOW DETECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY LATERAL FLOW DETECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAL TIME DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAL TIME DETECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAL TIME DETECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAL TIME DETECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAL TIME DETECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REAL TIME DETECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY STRAND DISPLACEMENT AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY STRAND DISPLACEMENT AMPLIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY STRAND DISPLACEMENT AMPLIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY STRAND DISPLACEMENT AMPLIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY STRAND DISPLACEMENT AMPLIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY STRAND DISPLACEMENT AMPLIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY POINT OF CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY POINT OF CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY POINT OF CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY POINT OF CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY POINT OF CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY POINT OF CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY FOOD & BEVERAGE TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY FOOD & BEVERAGE TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY FOOD & BEVERAGE TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY FOOD & BEVERAGE TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY FOOD & BEVERAGE TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY FOOD & BEVERAGE TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL ISOTHERMAL NUCLEIC